Rotavirus Infection
📧 Sign up to get email alerts when something new happens for Rotavirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants) [Phase 3]
A Phase 3 trial evaluated immunogenicity, reactogenicity, and safety of two formulations of GSK's Rotarix (live attenuated human rotavirus v…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine. [Phase 3]
A Phase 3 long-term follow-up study assessing efficacy and safety of GSK's HRV vaccine approximately 3 years after priming with 2 doses.
-
CLINICAL_TRIALS research · 2017-01-26Clinical Trial Update: The Influence of the Microbiome on Rotavirus Vaccine Immunogenic Response in Infants in Karachi, Pakistan
A completed clinical trial in Karachi, Pakistan, examined whether the gut microbiome influences the immunogenic response to the Rotavirus va…
-
CLINICAL_TRIALS research · 2016-12-21Clinical Trial Update: The Epidemiology and Etiology of Acute Gastroenteritis Among Estonian Children After Introduction of Rotavirus Vaccines
Observational study by the University of Tartu evaluating changes in the epidemiology and causes of acute gastroenteritis in Estonian childr…
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants [Phase 3]
A Phase 3 study tested two doses of GSK's Rotavirus vaccine (Rotarix) in healthy infants; the trial has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: To Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Bio HRV Liquid Vaccine Given to Infants (Vietnam) [Phase 3]
Phase 3 trial update assessing the immunogenicity, reactogenicity, and safety of two doses of GSK's HRV rotavirus vaccine given to infants i…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine in Healthy Infants [Phase 2]
A Phase 2 clinical trial evaluating two doses of an oral live attenuated HRV vaccine in healthy infants reports on efficacy, immune response…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants. [Phase 2]
A Phase 2 study completed evaluating two doses of GlaxoSmithKline's live attenuated human rotavirus vaccine in healthy infants, comparing tw…
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Vaccine Effectiveness of RV1 in a Naïve Population
Results from a completed clinical trial evaluating the RV1 rotavirus vaccine in a naive population have been posted. The study assessed vacc…
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: Pilot Study of the Rotavirus Vaccine in Infants With Intestinal Failure [Phase 4]
Phase 4 pilot trial of Rotavirus vaccine in infants with intestinal failure has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-17Clinical Trial Update: Drug Use Investigation for ROTARIX®
This is a completed clinical trial update on the ROTARIX vaccine for rotavirus infection sponsored by GlaxoSmithKline.
-
CLINICAL_TRIALS trial_result · 2015-07-22Clinical Trial Update: Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers [Phase 2]
Phase 2 clinical trial assessing safety and immune response of a rotavirus vaccine in HIV-infected and uninfected children born to HIV-infec…
-
CLINICAL_TRIALS withdrawal · 2015-03-27Clinical Trial Update: Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 Vaccine [Phase 2]
A Phase 2 study evaluating a birth dose of GlaxoSmithKline's 251154 rotavirus vaccine has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules [Phase 4]
Phase 4 clinical trial update reports safety and immunogenicity of sequential rotavirus vaccine schedules with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotavirus (RV) Vaccination
This completed study sponsored by GlaxoSmithKline analyzes the clinical and cost impact of complete versus incomplete rotavirus vaccination.
-
CLINICAL_TRIALS research · 2014-07-01Clinical Trial Update: Surveillance Study of Acute Gastroenteritis in Hospitalized Children in Rural Area in Lebanon
A surveillance clinical trial study in rural Lebanon monitors acute gastroenteritis in hospitalized children, focusing on diarrhea and Rotav…
-
CLINICAL_TRIALS research · 2014-06-03Clinical Trial Update: The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine [Phase 4]
Phase 4 study evaluating the safety and immunogenicity of a rotavirus vaccine when given together with MR or MMR vaccines.
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Two-year Surveillance of Rotavirus Genotypes Causing Acute Diarrhea in Children Younger Than 5 Years Requiring Emergency Room (ER) and Hospital Admission in Chile
This completed clinical trial reports two-year surveillance data on rotavirus genotypes causing acute diarrhea in children under 5 who requi…
-
CLINICAL_TRIALS trial_result · 2013-04-25Clinical Trial Update: Rotavirus Vaccine Produced by Butantan Institute [Phase 1]
Phase 1 clinical trial of a rotavirus vaccine produced by the Butantan Institute has completed, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Improving Rotavirus Vaccine Immune Response [Phase 3]
Phase 3 trial investigating methods to improve the immune response to the rotavirus vaccine; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-31Clinical Trial Update: Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children [Phase 2, Phase 3]
This document notes the completed Phase 2/Phase 3 trial of nitazoxanide suspension for diarrhea caused by enteric viruses in children, inclu…
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth. [Phase 4]
Phase 4 study assessing immunogenicity and safety of Rotarix in Taiwanese infants who received hepatitis B immunoglobulin at birth; results …
-
CLINICAL_TRIALS research · 2011-06-01Clinical Trial Update: Surveillance of Rotavirus Gastroenteritis in Children <5 Years
A clinical trial update on surveillance of rotavirus gastroenteritis in children under 5; the trial status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2011-04-12Clinical Trial Update: Consistency Lots Vaccine Study (V260-009) [Phase 3]
Phase 3 consistency lots study of a rotavirus vaccine (V260-009) sponsored by Merck Sharp & Dohme LLC has completed. Results were posted in …
-
CLINICAL_TRIALS trial_result · 2011-04-05Clinical Trial Update: Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children [Phase 2]
A Phase 2 efficacy study of nitazoxanide suspension for rotavirus disease in children has been completed.